MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Senogles, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Senogles, S. E.

Vol. 58, Issue 2, 455-462, August 2000

The D2s Dopamine Receptor Stimulates Phospholipase D Activity: A Novel Signaling Pathway for Dopamine

Susan E. Senogles

Department of Biochemistry, College of Medicine, University of Tennessee, Memphis, Tennessee

The D2 dopamine receptor isoforms signal to a variety of cellular effectors in both the central nervous system and periphery. Two alternative splice forms of the D2 dopamine receptor exist, the D2s (short) and D2l (long), which has an insertion of 29 amino acids in the third intracellular loop (Dal Taso et al., 1989). In cells of the anterior lobe of the pituitary, D2 dopamine receptors (both forms) are present on lactotroph cells coupled to the inhibition of adenylyl cyclase, activation of voltage-gated calcium channels, and inhibition of potassium channels. We describe here a novel signaling pathway for the D2s, which is the activation of phospholipase D (PLD). GH4C1 cells, a clonal line derived from a rat pituitary tumor, were stably transfected with the gene encoding the D2s, generating GH4-121 cells. Treatment of GH4-121 cells with a dopaminergic agonist resulted in activation of PLD in both a dose-dependent and time-dependent manner. This signaling pathway was not inhibited by prior treatment of cells with pertussis toxin at concentrations that ablate other D2s receptor signaling in this cell line. The stimulation of PLD activity by D2s appeared to correlate with the presence of a specific protein kinase C isoform, PKCepsilon . The D2s stimulation of PLD activity was blocked by preincubation of cells with C3 exoenzyme, indicating that the stimulation of PLD may involve Rho family members. The stimulation of PLD by dopaminergic agonists took place in the absence of any detectable stimulation of phosphoinositide metabolism.

Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
L. V. Neto, E. d. O. Machado, R. M. Luque, G. F. Taboada, J. B. Marcondes, L. M. C. Chimelli, L. P. Quintella, P. Niemeyer Jr., D. P. de Carvalho, R. D. Kineman, et al.
Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1931 - 1937.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
B. Pan, C. J. Hillard, and Q.-s. Liu
D2 Dopamine Receptor Activation Facilitates Endocannabinoid-Mediated Long-Term Synaptic Depression of GABAergic Synaptic Transmission in Midbrain Dopamine Neurons via cAMP-Protein Kinase A Signaling
J. Neurosci., December 24, 2008; 28(52): 14018 - 14030.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. Pivonello, D. Ferone, G. Lombardi, A. Colao, S. W J Lamberts, and L. J Hofland
Novel insights in dopamine receptor physiology
Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S13 - S21.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. H. Yin and D. M. Lovinger
Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling
PNAS, May 23, 2006; 103(21): 8251 - 8256.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Glaser, D. Alvaro, T. Roskams, J. L. Phinizy, G. Stoica, H. Francis, Y. Ueno, B. Barbaro, M. Marzioni, J. Mauldin, et al.
Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity
Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G683 - G694.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Koch, L.-O. Brandenburg, S. Schulz, Y. Liang, J. Klein, and V. Hollt
ADP-ribosylation Factor-dependent Phospholipase D2 Activation Is Required for Agonist-induced {micro}-Opioid Receptor Endocytosis
J. Biol. Chem., March 7, 2003; 278(11): 9979 - 9985.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Rasolonjanahary, C. Gerard, M. N. Dufour, V. Homburger, A. Enjalbert, and G. Guillon
Evidence for a Direct Negative Coupling between Dopamine-D2 Receptors and PLC by Heterotrimeric Gi1/2 Proteins in Rat Anterior Pituitary Cell Membranes
Endocrinology, March 1, 2002; 143(3): 747 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev., December 1, 2001; 22(6): 724 - 763.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics